Alka-seltzer Heartburn Relief Lemon Lime

Dosage of Citric Acid and its conjugate salts is highly individualized based on the patient's acid-base status and the specific condition being treated.

• For Urinary Alkalization/Kidney Stone Prevention: The typical adult dose is 10 to 30 mL of an oral solution (containing roughly 1 gram of citric acid and 1.5 grams of sodium/potassium citrate) diluted in water, taken four times daily after meals and at bedtime. Alternatively, 15-30 mEq of citrate salts may be administered 2-4 times daily.
• For Metabolic Acidosis: Dosing is adjusted to maintain a desired urinary pH (usually between 6.0 and 7.0) and serum bicarbonate levels. This often requires 30-60 mL of solution per day in divided doses.
• H. pylori Diagnostic Test: A single dose of approximately 4 grams of citric acid powder is dissolved in water and consumed as part of the test protocol.

Citric Acid is used in children, but dosing must be calculated carefully, usually based on body weight or surface area.

• General Pediatric Dosing: 5 to 15 mL of oral solution diluted in water, taken 2 to 4 times daily after meals.
• Neonatal Use: Use in neonates is rare and must be managed by a specialist, as their renal handling of acid-base balance is immature.

Renal Impairment

In patients with significant renal impairment (GFR < 30 mL/min), Citric Acid combinations containing potassium must be used with extreme caution to avoid hyperkalemia (high potassium). Conversely, sodium-containing versions may contribute to fluid retention and should be avoided in patients with renal failure or congestive heart failure.

Hepatic Impairment

Since the liver is the primary site for the conversion of citrate to bicarbonate, patients with severe hepatic insufficiency may have a reduced alkalizing response. Monitoring of systemic pH is essential.

Elderly Patients

Elderly patients are more likely to have reduced renal function and may be taking other medications (like ACE inhibitors) that affect potassium levels. Dose selection should be cautious, usually starting at the lower end of the dosing range.

1. 1Dilution is Mandatory: If using the liquid concentrate, you must dilute the dose in at least 6 to 8 ounces of water or juice. Taking the concentrate undiluted can cause severe gastrointestinal irritation and potentially chemical burns in the esophagus.
2. 2Timing: To minimize stomach upset, take Citric Acid after meals. The 'bedtime dose' should be taken after a small snack.
3. 3Hydration: Patients taking Citric Acid for kidney stones must maintain high fluid intake (2-3 liters per day) to ensure adequate urine volume.
4. 4Storage: Store at room temperature (20°C to 25°C). Keep the bottle tightly closed and protect it from freezing or excessive heat.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this can lead to acute electrolyte imbalances or metabolic alkalosis.

Signs of Citric Acid overdose (specifically when taken with salts) include:

• Severe muscle weakness or 'heaviness' in the legs.
• Cardiac arrhythmias (irregular heartbeat).
• Tingling in the hands or feet.
• Severe abdominal pain or vomiting.
• Metabolic alkalosis (symptoms include confusion, tremors, and lightheadedness).

In case of suspected overdose, contact a poison control center or seek emergency medical attention immediately. Treatment usually involves correcting electrolyte imbalances and, in severe cases, dialysis.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this can cause your urinary pH to drop and increase the risk of stone formation.

Gastrointestinal symptoms are the most frequently reported side effects of Citric Acid therapy, particularly when using oral solutions. These include:

• Stomach Pain/Cramping: Often described as a dull ache or 'knot' in the stomach shortly after taking the dose.
• Nausea and Vomiting: This is typically mild but can be persistent if the medication is not properly diluted.
• Diarrhea: Citrate salts can have an osmotic effect in the bowel, leading to loose stools. This usually resolves as the body adjusts to the medication.

• Fluid Retention (Edema): Especially with sodium-based formulations, patients may notice swelling in the ankles, feet, or hands.
• Eructation (Burping): The effervescent nature of some Citric Acid powders can lead to increased gas and bloating.
• Mild Metabolic Alkalosis: Some patients may feel slightly lightheaded or experience a metallic taste in the mouth.

• Hyperkalemia: Specifically with potassium citrate/citric acid combinations, this can lead to dangerous heart rhythm changes.
• Tetany: In rare cases, the alkalizing effect can lower ionized calcium levels, leading to muscle twitches or 'pins and needles' sensations.
• Gastrointestinal Ulceration: Extremely rare, but possible if the medication is taken with insufficient water or on an empty stomach over long periods.

> Warning: Stop taking Citric Acid and call your doctor immediately if you experience any of the following:

1. 1Signs of High Potassium (Hyperkalemia): Slow or irregular heartbeat, profound muscle weakness, or a feeling like you might pass out.
2. 2Severe Abdominal Distress: Black, tarry stools or vomit that looks like coffee grounds (indicating potential GI bleeding).
3. 3Allergic Reaction (Anaphylaxis): While rare for citric acid itself, components in the formulation can cause hives, difficulty breathing, or swelling of the face and throat.
4. 4Seizures or Confusion: These may be signs of severe metabolic alkalosis or electrolyte shifts.
5. 5Reduced Urine Output: This could indicate a change in kidney function that requires immediate assessment.

Prolonged use of Citric Acid for urinary alkalization requires ongoing monitoring. Long-term effects can include:

• Renal Calcification: Paradoxically, if the urine becomes too alkaline (pH > 7.5), it can increase the risk of calcium phosphate stone formation.
• Chronic Electrolyte Imbalance: Constant supplementation with sodium or potassium can stress the kidneys' regulatory mechanisms.
• Dental Erosion: Because citric acid is an acid before it is metabolized, frequent contact with teeth (if not swallowed quickly or if the mouth is not rinsed) can weaken tooth enamel.

There are currently no FDA black box warnings for Citric Acid or its common combinations (such as Shohl's solution). However, this does not imply the medication is without risk; it must be used strictly under medical supervision, especially in patients with heart or kidney disease.

Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.

Citric Acid therapy is generally safe when used as directed, but it carries significant risks if the patient has underlying conditions that affect electrolyte or acid-base regulation. The most critical safety point is the requirement for dilution. Citric acid is a caustic substance in concentrated form; failure to dilute it properly can lead to esophageal injury or severe gastric irritation.

No FDA black box warnings for Citric Acid.

Allergic Reactions / Anaphylaxis Risk

While Citric Acid is a natural substance, pharmaceutical preparations often contain dyes (like FD&C Yellow No. 5), flavorings, and preservatives (like sodium benzoate). Patients with known sensitivities to these additives should review the full ingredient list with their pharmacist.

Organ-Specific Risks

• Cardiovascular: Sodium-containing Citric Acid products can cause sodium retention and exacerbate congestive heart failure (CHF), hypertension, or edema. Potassium-containing products can cause life-threatening arrhythmias in patients with heart disease.
• Renal: In patients with chronic kidney disease (CKD), the kidneys cannot efficiently clear potassium or sodium, making Citric Acid combinations potentially dangerous. There is also a risk of systemic alkalosis if the kidneys cannot excrete the excess bicarbonate generated from citrate metabolism.
• Gastrointestinal: Patients with a history of peptic ulcer disease or delayed gastric emptying should use Citric Acid with caution, as it can aggravate these conditions.

Monitoring Requirements

Patients on long-term Citric Acid therapy must undergo regular laboratory testing. This includes:

• Serum Electrolytes: Frequent monitoring of potassium, sodium, and chloride levels.
• Renal Function: Creatinine and BUN tests to ensure the kidneys are handling the treatment.
• Urinary pH: Often measured by the patient at home using pH strips to ensure the dose is achieving the target range (usually 6.2 to 6.8).
• Bicarbonate/CO2 Levels: To monitor for systemic alkalosis.

Citric Acid does not typically cause drowsiness or cognitive impairment. However, if a patient experiences lightheadedness due to electrolyte shifts or alkalosis, they should avoid driving until the symptoms resolve.

Alcohol should be used with caution. Alcohol can contribute to dehydration and metabolic changes that may counteract the benefits of Citric Acid in preventing kidney stones. Additionally, alcohol can increase the risk of gastric irritation when taken alongside Citric Acid.

Do not stop taking Citric Acid suddenly if you are being treated for chronic metabolic acidosis or recurrent kidney stones. Abrupt discontinuation can lead to a rapid drop in urinary pH, potentially triggering the formation of new stones. If the medication must be stopped, your doctor will likely monitor your blood and urine chemistry closely during the transition.

> Important: Discuss all your medical conditions, especially heart disease, kidney disease, or high blood pressure, with your healthcare provider before starting Citric Acid.

• Aluminum-Containing Antacids: Citric Acid significantly increases the absorption of aluminum. In patients with renal failure, this can lead to acute aluminum toxicity, which is toxic to the brain (encephalopathy) and bones. Do not take antacids containing aluminum hydroxide while taking Citric Acid.
• Potassium-Sparing Diuretics: (e.g., Spironolactone, Triamterene, Amiloride). Taking these with potassium-based Citric Acid formulations can lead to severe, potentially fatal hyperkalemia.

• ACE Inhibitors and ARBs: (e.g., Lisinopril, Losartan). These blood pressure medications also increase potassium levels. Combining them with potassium citrate/citric acid requires frequent blood tests.
• Digitalis Glycosides: (e.g., Digoxin). Changes in potassium levels (either high or low) can increase the risk of digoxin toxicity and dangerous heart rhythms.
• Salicylates: (e.g., Aspirin). Citric acid-induced urinary alkalization can increase the renal excretion of salicylates, potentially reducing their effectiveness.

• Amphetamines and Quinidine: Alkalinizing the urine reduces the renal clearance of these drugs, which can lead to increased blood levels and potential toxicity.
• Methenamine: This urinary tract infection medication requires an acidic urine (pH < 5.5) to work. Citric Acid will raise the pH and make methenamine ineffective.
• Corticosteroids: May promote sodium retention, which can be exacerbated by sodium-containing Citric Acid formulations.

• High-Sodium Diet: Excessive salt intake can counteract the effects of Citric Acid in preventing calcium stones.
• Dairy Products: Large amounts of calcium-rich foods might interact with the citrate in the gut, although this is usually managed by taking the medication after meals.
• Licorice: Natural licorice can affect electrolyte balance (lowering potassium), which may complicate Citric Acid therapy.

• Dandelion: May act as a diuretic and affect potassium levels.
• St. John's Wort: While no direct metabolic interaction is known, it can affect the overall chemical balance in some patients.

Citric Acid therapy can affect several laboratory results:

• Urinary pH: Will be intentionally increased.
• Serum Bicarbonate: Will be increased.
• Serum Potassium/Sodium: May be altered depending on the salt form used.
• Urinary Calcium: Often decreased as citrate complexes with calcium.

Mechanism of Interactions: Most interactions are either pharmacodynamic (additive effects on potassium/sodium levels) or related to urinary pH changes (altering the ionization and excretion of other drugs). The aluminum interaction is a unique absorption-based interaction where citrate chelates aluminum, making it more soluble and easily absorbed.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Carry a list of your medications at all times.

Citric Acid combinations must NEVER be used in the following circumstances:

1. 1Severe Renal Impairment with Oliguria or Azotemia: If the kidneys are not producing enough urine, they cannot excrete the electrolytes (potassium/sodium) or the bicarbonate produced, leading to life-threatening toxicity.
2. 2Untreated Addison's Disease: This condition involves adrenal insufficiency and a high risk of hyperkalemia, which Citric Acid (potassium salt) would exacerbate.
3. 3Acute Dehydration: Electrolyte imbalances are already present, and Citric Acid can worsen the instability.
4. 4Severe Myocardial Damage: The risk of cardiac arrest from potassium shifts is too high.
5. 5Hyperkalemia: Any condition where potassium levels are already elevated.

These conditions require a careful risk-benefit analysis by a physician:

• Congestive Heart Failure (CHF): Sodium-based products can lead to fluid overload and pulmonary edema.
• Active Peptic Ulcer: The acidic nature of the undigested dose can cause pain or bleeding.
• Urinary Tract Infection (UTI) with Urea-Splitting Bacteria: These bacteria already raise urinary pH; adding Citric Acid may promote the formation of 'struvite' (infection) stones.

Patients who have had a severe allergic reaction to any citrate salt (sodium, potassium, or calcium citrate) should avoid Citric Acid formulations. While Citric Acid itself is rarely the allergen, the complex formulations often share similar excipients, such as benzoate preservatives or specific citrus flavorings, which can trigger cross-reactions.

> Important: Your healthcare provider will evaluate your complete medical history, including your latest blood work, before prescribing Citric Acid.

FDA Pregnancy Category C. There are no adequate and well-controlled studies of Citric Acid in pregnant women. It is not known whether Citric Acid can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. However, maintaining acid-base balance is critical during pregnancy. Citric Acid should be given to a pregnant woman only if clearly needed and under strict medical supervision. Monitoring for fluid retention (edema) is particularly important in the third trimester to avoid complications like preeclampsia.

Citric acid is a normal constituent of human milk. When taken at therapeutic doses, it is unlikely to significantly alter the citrate content of breast milk or affect the nursing infant. However, because the medication is often taken as a salt (sodium or potassium), the mother's electrolyte balance should be monitored. Always consult a healthcare provider before breastfeeding while on chronic therapy.

Citric Acid is approved for use in children for the treatment of metabolic acidosis and certain renal conditions. It is particularly useful in pediatric distal renal tubular acidosis (dRTA). However, long-term safety data regarding bone growth and dental health are limited. Dosing must be precisely adjusted by a pediatric nephrologist. It is NOT approved for use in infants without specialist oversight due to the risk of immature renal handling of large acid/base loads.

Older adults are at a significantly higher risk for side effects.

• Renal Clearance: Natural decline in GFR with age increases the risk of potassium or sodium accumulation.
• Polypharmacy: Seniors are more likely to be taking interacting drugs like diuretics, ACE inhibitors, or NSAIDs.
• Fall Risk: Electrolyte shifts can occasionally cause transient dizziness, increasing the risk of falls in the elderly.

In patients with mild to moderate renal impairment, Citric Acid can be used but requires frequent monitoring. In severe renal impairment (GFR < 30), the risk of metabolic alkalosis and hyperkalemia/hypernatremia is extremely high. Sodium citrate/citric acid is often preferred over potassium versions in these patients, provided they can tolerate the sodium load.

Patients with cirrhosis or severe liver failure may have impaired metabolism of citrate to bicarbonate. This can lead to a 'citrate gap' where the alkalizing effect is delayed or diminished. These patients also often have complex fluid balance issues (ascites), making the choice of sodium vs. potassium salts critical.

> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring.

Citric Acid (C6H8O7) is a weak organic acid. In the body, its primary role is as a metabolic intermediate. When administered orally as an alkalizing agent, the citrate anion is absorbed and oxidized in the liver to form three molecules of bicarbonate (HCO3-). This bicarbonate then enters the systemic circulation, raising the blood pH.

In the kidneys, the increased bicarbonate load leads to an increase in urinary pH. Furthermore, the presence of citrate in the renal tubules provides a dual benefit:

1. 1It complexes with calcium, reducing the saturation of calcium oxalate.
2. 2It directly inhibits the spontaneous nucleation and crystal growth of calcium oxalate and calcium phosphate.

The onset of action for urinary alkalization is relatively rapid, with changes in urinary pH typically observed within 1 to 2 hours after a dose. The duration of effect is short (4 to 6 hours), which is why multiple daily doses are required to maintain a consistent urinary pH. There is no evidence of tolerance development; the body's response to Citric Acid remains consistent over long-term therapy provided renal and hepatic functions are stable.

| Parameter | Value |

|---|---|

| Bioavailability | >95% (as citrate) |

| Protein Binding | Low (<5%) |

| Half-life | ~0.5 to 1.5 hours (plasma citrate) |

| Tmax | 0.5 to 1.0 hours |

| Metabolism | Hepatic (Krebs Cycle) |

| Excretion | Renal (<5% unchanged), Lungs (as CO2) |

• Molecular Formula: C6H8O7 · H2O (Monohydrate)
• Molecular Weight: 210.14 g/mol
• Solubility: Highly soluble in water (approx. 1630 g/L at 20°C); soluble in ethanol.
• Description: Colorless crystals or white crystalline powder with a strongly acidic taste. It is efflorescent in dry air.

Citric Acid is classified as a Urinary Alkalinizer and a Systemic Alkalinizer. It is often grouped with other electrolyte replenishers and buffering agents. In the context of H. pylori diagnostics, it is considered a Diagnostic Acidifying Agent.